Evaluation of disease severity and treatment intensity as cost drivers for ruptured intracranial aneurysms.

These results show for the first time that disease and vasospasm severity and intensity of treatment directly impact the cost of care for patients with aneurysms in the USA. Strategies to alter these variables may prove important for cost reduction.